Thrombin topical (Recombinant) (Recothrom)
Thrombin topical (Recombinant) is an FDA-licensed reference biologic from Baxter Healthcare Corporation. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2008
Reference approved
Reference product
Recothrom Thrombin topical (Recombinant)
Baxter Healthcare Corporation
- Approved
- May 23, 2008
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Thrombin topical (Recombinant), in chronological order.
Reference approval
Approval date of the reference Thrombin topical (Recombinant) product.
18 yr 3 mo ago
Frequently asked questions
Are there biosimilars approved for Thrombin topical (Recombinant) (Recothrom)?
No 351(k) biosimilars or interchangeable biosimilars referencing Thrombin topical (Recombinant) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.